The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis.

Anotace

do not confuse with DESIGNER DRUGS

nepleť s deskriptorem NOVÉ SYNTETICKÉ DROGY

DUI

D015195 MeSH Prohlížeč

CUI

M0023350

Předchozí užití

Chemistry, Pharmaceutical (1966-1988); Drugs (1966-1988)

Historická pozn.

89

Veřejná pozn.

89